GSK Acquires BP Asset IX Inc. For $2 Bln To Advance Efimosfermin In SLD Treatment

(RTTNews) - GSK plc (GSK, GSK.L) has entered into an agreement to acquire Boston Pharmaceuticals' BP Asset IX Inc. for $2 billion in total cash consideration, comprising a $1.2 billion upfront payment and up to $800 million in success-based milestone payments. Additionally, GSK w https://www.nasdaq.com/articles/gsk-acquires-bp-asset-ix-inc-2-bln-advance-efimosfermin-sld-treatment